Wyres KL, Lam MM, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol. 2020;18(6):344–59.

Article  CAS  PubMed  Google Scholar 

Hawkey PM, Livermore DM. Carbapenem antibiotics for serious infections. BMJ. 2012; 344.

Siu LK, Yeh K-M, Lin J-C, Fung C-P, Chang F-Y. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12(11):881–7.

Article  PubMed  Google Scholar 

Lan P, Jiang Y, Zhou J, Yu Y. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist. 2021;25:26–34.

Article  CAS  PubMed  Google Scholar 

Li Y, Kumar S, Zhang L. Mechanisms of antibiotic resistance and developments in therapeutic strategies to combat Klebsiella pneumoniae infection. Infect Drug Resist. 2024:1107–19.

Brink AJ. Epidemiology of carbapenem-resistant Gram-negative infections globally. Curr Opin Infect Dis. 2019;32(6):609–16.

Article  CAS  PubMed  Google Scholar 

Han Y-L, Wen X-H, Zhao W, Cao X-S, Wen J-X, Wang J-R, Hu Z-D, Zheng W-Q. Epidemiological characteristics and molecular evolution mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Front Microbiol. 2022;13:1003783.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Zeng J, Liu W, Zhao F, Hu Z, Zhao C, Wang Q, Wang X, Chen H, Li H. Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China. J Infect. 2015;71(5):553–60.

Article  PubMed  Google Scholar 

Doumith M, Ellington MJ, Livermore DM, Woodford N. Molecular mechanisms disrupting Porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. Clinical isolates from the UK. J Antimicrob Chemother. 2009;63(4):659–67.

Article  CAS  PubMed  Google Scholar 

Xu Q, Sheng Z, Hao M, Jiang J, Ye M, Chen Y, Xu X, Guo Q, Wang M. RamA upregulates multidrug resistance efflux pumps acrab and OqxAB in Klebsiella pneumoniae. Int J Antimicrob Agents. 2021;57(2):106251.

Article  CAS  PubMed  Google Scholar 

Li Y, Ni M. Regulation of biofilm formation in Klebsiella pneumoniae. Front Microbiol. 2023;14:1238482.

Article  PubMed  PubMed Central  Google Scholar 

Guerra MES, Destro G, Vieira B, Lima AS, Ferraz LFC, Hakansson AP, Darrieux M, Converso TR. Klebsiella pneumoniae biofilms and their role in disease pathogenesis. Front Cell Infect Microbiol. 2022;12:877995.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabença C, Costa E, Sousa S, Barros L, Oliveira A, Ramos S, Igrejas G, Torres C, Poeta P. Evaluation of the ability to form biofilms in KPC-producing and ESBL-producing Klebsiella pneumoniae isolated from clinical samples. Antibiotics. 2023;12(7):1143.

Article  PubMed  PubMed Central  Google Scholar 

Di Domenico EG, Cavallo I, Sivori F, Marchesi F, Prignano G, Pimpinelli F, Sperduti I, Pelagalli L, Di Salvo F, Celesti I. Biofilm production by carbapenem-resistant Klebsiella pneumoniae significantly increases the risk of death in oncological patients. Front Cell Infect Microbiol. 2020;10:561741.

Article  PubMed  PubMed Central  Google Scholar 

WHO. WHO bacterial priority pathogens list. 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. 2024.

Lewis K. The science of antibiotic discovery. Cell. 2020;181(1):29–45.

Article  CAS  PubMed  Google Scholar 

Fang Q, Zong Z. Lytic phages against ST11 K47 Carbapenem-Resistant Klebsiella pneumoniae and the corresponding phage resistance mechanisms. mSphere. 2022;7(2):e00080–00022.

Article  PubMed  PubMed Central  Google Scholar 

Assoni L, Girardello R, Converso TR, Darrieux M. Current stage in the development of Klebsiella pneumoniae vaccines. Infect Dis Ther. 2021;10(4):2157–75.

Article  PubMed  PubMed Central  Google Scholar 

Valenzuela-Valderrama M, González IA, Palavecino CE. Photodynamic treatment for multidrug-resistant Gram-negative bacteria: perspectives for the treatment of Klebsiella pneumoniae infections. Photodiagnosis Photodyn Ther. 2019;28:256–64.

Article  CAS  PubMed  Google Scholar 

Barani M, Fathizadeh H, Arkaban H, Kalantar-Neyestanaki D, Akbarizadeh MR, Turki Jalil A, Akhavan-Sigari R. Recent advances in nanotechnology for the management of Klebsiella pneumoniae–related infections. Biosensors. 2022;12(12):1155.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Souza CM, da Silva ÁP, Júnior NGO, Martínez OF, Franco OL. Peptides as a therapeutic strategy against Klebsiella pneumoniae. Trends Pharmacol Sci. 2022;43(4):335–48.

Article  PubMed  Google Scholar 

Gholizadeh O, Ghaleh HEG, Tat M, Ranjbar R, Dorostkar R. The potential use of bacteriophages as antibacterial agents against Klebsiella pneumoniae. Virol J. 2024;21(1):191.

Article  PubMed  PubMed Central  Google Scholar 

Duan Y, Young R, Schnabl B. Bacteriophages and their potential for treatment of Gastrointestinal diseases. Nat Rev Gastroenterol Hepatol. 2022;19(2):135–44.

Article  CAS  PubMed  Google Scholar 

Brives C, Pourraz J. Phage therapy as a potential solution in the fight against AMR: Obstacles and possible futures. Palgrave Commun. 2020;6(1):1–11.

Article  Google Scholar 

CLSI. Performance standards for antimicrobial susceptibility Testing;33rd edition. CLSI document M100-S33. Wayne, PA: Clinical and Laboratory Standards Institute; 2023.

Google Scholar 

EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, version 13.1. 2023.

Fayez MS, Hakim TA, Zaki BM, Makky S, Abdelmoteleb M, Essam K, Safwat A, Abdelsattar AS, El-Shibiny A. Morphological, biological, and genomic characterization of Klebsiella pneumoniae phage vB_Kpn_ZC2. Virol J. 2023;20(1):86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang C, Dai X, Xiang L, Qiu Y, Yin M, Fu Y, Li Y, Zhang L. Isolation and characterization of three novel lytic phages against K54 serotype carbapenem-resistant hypervirulent Klebsiella pneumoniae. Front Cell Infect Microbiol 2023; 13.

Gou Z, Yao P, Xiong L, Wang X, Yuan Q, Sun F, Cheng Y, Xia P. Potential of a phage cocktail in the treatment of multidrug-resistant Klebsiella pneumoniae pulmonary infection in mice. BMC Microbiol. 2025;25(1):151.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ananna NT, Shishir TA, Ahmed A, Al Sium SM, Shakil MS, Haque FKM, Hasanuzzaman M. Characterization of two lytic bacteriophages infecting carbapenem-resistant clinical Klebsiella pneumoniae in dhaka, Bangladesh. Virus Res. 2024;350:199491.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Feng J, Cui X, Huang L, Du B, Xia Y, Xue G, Feng Y, Ke Y, Zhao H. Genomic analysis and therapeutic efficacy evaluation of bacteriophage PK2420 for pneumonia caused by hypervirulent Klebsiella pneumoniae (K20 serotype). mSystems. 2025;10(5):e01632–01624.

Article  PubMed  PubMed Central  Google Scholar 

Li M, Guo M, Chen L, Zhu C, Xiao Y, Li P, Guo H, Chen L, Zhang W, Du H. Isolation and characterization of novel lytic bacteriophages infecting epidemic carbapenem-resistant Klebsiella pneumoniae strains. Front Microbiol. 2020;11:1554.

Article  PubMed  PubMed Central  Google Scholar 

Mulani MS, Kumkar SN, Pardesi KR. Characterization of novel Klebsiella phage PG14 and its antibiofilm efficacy. Microbiol Spectr. 2022;10(6):e01994–01922.

Article  PubMed  PubMed Central  Google Scholar 

Qasim N, Shahid M, Yousaf F, Riaz M, Anjum F, Faryad MA, Shabbir R. Therapeutic potential of selected varieties of phoenix dactylifera L. Against microbial biofilm and free radical damage to DNA. Dose-Response. 2020;18(4):1559325820962609.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13(6):e1005595.

Article